ClinicalTrials.Veeva

Menu

BIO|STREAM.ICM Obesity

B

Biotronik

Status

Completed

Conditions

Bradycardia
Syncope
Atrial Fibrillation
Cryptogenic Stroke
Tachycardia Atrial

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The aim of the submodule study is to assess whether a high BMI may influence the sensing performance and the sECG quality of the BIOMONITOR.

Full description

This submodule of the BIO|STREAM.ICM registry specifically investigates the performance of the BIOMONITOR in a subset of obese patients with a BMI >30 kg/m2 in order to exclude any concerns regarding impaired ICM sensing performance. These concerns are founded in the increased distance between heart and device electrodes due to fat layers that may attenuate signal detection and therefore sensing performances of the ICM.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is already enrolled in the BIO|STREAM.ICM registry
  • Patient BMI > 30

Exclusion criteria

  • Patient clinically indicated for or already implanted with another cardiac active device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems